Stay updated on APL-2 in Neovascular AMD Clinical Trial
Sign up to get notified when there's something new on the APL-2 in Neovascular AMD Clinical Trial page.

Latest updates to the APL-2 in Neovascular AMD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior notices including a lapse in government funding (v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a government funding lapse notice regarding site status and operations, and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedGlossary visibility has been added to the page. Metadata labels were updated (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) replacing the prior wording (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).SummaryDifference0.2%

- Check42 days agoChange DetectedAdded: Revision: v3.3.4 and removed: Revision: v3.3.3, minor administrative updates to the site version that do not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedLocations section reorganized to consolidate site listings under a single Locations heading, now including CA, MD, OH, and TX entries, with the revision updated to v3.3.3.SummaryDifference0.6%

- Check92 days agoChange DetectedThe page now lists revision: v3.3.2 in the study documents area, replacing v3.2.0.SummaryDifference0.1%

Stay in the know with updates to APL-2 in Neovascular AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-2 in Neovascular AMD Clinical Trial page.